These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9543390)

  • 41. The role of nitric oxide on the proliferation of a human osteoblast cell line stimulated with hydroxyapatite.
    Sosroseno W; Sugiatno E; Samsudin AR; Ibrahim F
    J Oral Implantol; 2008; 34(4):196-202. PubMed ID: 18780564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma.
    Shih YH; Chang KW; Chen MY; Yu CC; Lin DJ; Hsia SM; Huang HL; Shieh TM
    Head Neck; 2013 Feb; 35(2):250-6. PubMed ID: 22367676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of type 2 nitric oxide synthase and p21 in oral squamous cell carcinoma.
    Brennan PA; Palacios-Callender M; Umar T; Tant S; Langdon JD
    Int J Oral Maxillofac Surg; 2002 Apr; 31(2):200-5. PubMed ID: 12102420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma.
    Castle V; Varani J; Fligiel S; Prochownik EV; Dixit V
    J Clin Invest; 1991 Jun; 87(6):1883-8. PubMed ID: 2040684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased expression of inducible nitric oxide synthase for human oral submucous fibrosis, verrucous hyperplasia, and verrucous carcinoma.
    Chen YK; Hsuen SS; Lin LM
    Int J Oral Maxillofac Surg; 2002 Aug; 31(4):419-22. PubMed ID: 12361077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microencapsulated iNOS-expressing cells cause tumor suppression in mice.
    Xu W; Liu L; Charles IG
    FASEB J; 2002 Feb; 16(2):213-5. PubMed ID: 11772948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenously produced nitric oxide increases tumor necrosis factor-alpha production in transfected human U937 cells.
    Yan L; Wang S; Rafferty SP; Wesley RA; Danner RL
    Blood; 1997 Aug; 90(3):1160-7. PubMed ID: 9242548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of retinoids on nitric oxide production by promonocytic U937 cells and ZR-75-1 human breast cancer cells.
    Martin JH; Alalami O; Yaqoob F
    Oncol Rep; 2000; 7(2):219-23. PubMed ID: 10671661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nitric oxide synthase evaluation in oral precancerous and cancerous lesions.
    Mastrangelo F; Vinci R; Falco G; Tettamanti L; Tetè S; Tagliabue A; Gherlone E
    J Biol Regul Homeost Agents; 2014; 28(4):767-73. PubMed ID: 25620185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth.
    Searles CD; Ide L; Davis ME; Cai H; Weber M
    Circ Res; 2004 Sep; 95(5):488-95. PubMed ID: 15256481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do tobacco stimulate the production of nitric oxide by up regulation of inducible nitric oxide synthesis in cancer: Immunohistochemical determination of inducible nitric oxide synthesis in oral squamous cell carcinoma--a comparative study in tobacco habituers and non-habituers.
    Karthik B; Shruthi DK; Singh J; Tegginamani AS; Kudva S
    J Cancer Res Ther; 2014; 10(2):244-50. PubMed ID: 25022373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery.
    Sonveaux P; Dessy C; Brouet A; Jordan BF; Grégoire V; Gallez B; Balligand JL; Feron O
    FASEB J; 2002 Dec; 16(14):1979-81. PubMed ID: 12397083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene therapy in cancer via use of a retrovector having a tumor specificity and expressing inducible nitric oxide synthase.
    Kuroki M
    Methods Mol Biol; 2004; 279():201-11. PubMed ID: 15199247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene transfer of nitric oxide synthase: effects on endothelial biology.
    Niebauer J; Dulak J; Chan JR; Tsao PS; Cooke JP
    J Am Coll Cardiol; 1999 Oct; 34(4):1201-7. PubMed ID: 10520813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of nitric oxide is a good therapeutic target for bladder tumors that express iNOS.
    Belgorosky D; Langle Y; Prack Mc Cormick B; Colombo L; Sandes E; Eiján AM
    Nitric Oxide; 2014 Jan; 36():11-8. PubMed ID: 24211345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental study of recombinant eukaryotic expression vector of human eNOS in ECV304.
    Qiao T; Liu CJ; Ran F; Han L; Zhang L; Li L
    Swiss Med Wkly; 2006 Jan; 136(1-2):19-25. PubMed ID: 16597095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene.
    Juang SH; Xie K; Xu L; Shi Q; Wang Y; Yoneda J; Fidler IJ
    Hum Gene Ther; 1998 Apr; 9(6):845-54. PubMed ID: 9581907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Posttranscriptional regulation of endothelial nitric oxide synthase during cell growth.
    Searles CD; Miwa Y; Harrison DG; Ramasamy S
    Circ Res; 1999 Oct; 85(7):588-95. PubMed ID: 10506483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma.
    Romero LI; Zhang DN; Cooke JP; Ho HK; Avalos E; Herrera R; Herron GS
    Vasc Med; 2000; 5(3):147-58. PubMed ID: 11104297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor cell-derived nitric oxide is involved in the immune-rejection of an immunogenic murine lymphoma.
    Hu DE; Dyke SO; Moore AM; Thomsen LL; Brindle KM
    Cancer Res; 2004 Jan; 64(1):152-61. PubMed ID: 14729619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.